Antagonist, Partial Agonist and Antiproliferative Actions of B-9870 (CU201) as a Function of the Expression and Density of the Bradykinin B1and B2receptors

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0706982
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Bradykinin B1and B2receptors, Tumour Necrosis Factorαand Inflammatory Hyperalgesia

British Journal of Pharmacology
Pharmacology
1999English

Agonist-Independent Nuclear Localization of the Apelin, Angiotensin AT1, and Bradykinin B2Receptors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Δ9-Tetrahydrocannabinol Acts as a Partial Agonist/Antagonist in Mice

Behavioural Pharmacology
PsychiatryMental HealthPharmacology
2012English

Inhibition of Bradykinin- And Kallikrein-Induced Cerebral Arteriolar Dilation by a Specific Bradykinin Antagonist

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1987English

PROPERTIES OF THE TRPV4 AGONIST GSK1016790A AND the TRPV4 ANTAGONIST GSK2193874

Physiological Reviews
MedicinePhysiologyMolecular Biology
2017English

B2R of Bradykinin Activated by Proteases * Response: Does the Bradykinin B2 Receptor Function as a Protease-Activated Receptor?

Hypertension
Internal Medicine
2003English

Effects of Hoe 140, a Bradykinin B2-Receptor Antagonist, on Renal Function in Conscious Normotensive Rats

British Journal of Pharmacology
Pharmacology
1992English

Effects of Cuminum Cyminum Essence on Rat Ovary Function Following Administration of Dopaminergic Agonist and Antagonist

Journal of Ilam University of Medical Sciences
2018English

Investigation of the Actions and Antagonist Activity of Some Polyamine Analoguesin Vivo

British Journal of Pharmacology
Pharmacology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy